Literature DB >> 6248093

Electron spin resonance studies on caeruloplasmin and iron transferrin in patients with chronic lymphocytic leukaemia.

J A Green, T Pocklington, A A Dawson, M Foster.   

Abstract

Whole-blood caeruloplasmin measured by electron spin resonance was studied in 41 patients with chronic lymphocytic leukaemia. The levels were above normal at all stages of the disease, rose with increasing clinical involvement, and were higher in progressive than inactive disease. Whole-blood iron transferrin levels were more variable, and were significantly raised only in patients with marrow failure.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6248093      PMCID： PMC2010244          DOI： 10.1038/bjc.1980.58

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  15 in total

1.  Clinical staging of chronic lymphocytic leukemia.

Authors:  K R Rai; A Sawitsky; E P Cronkite; A D Chanana; R N Levy; B S Pasternack
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

2.  Electron spin resonance measurements of blood caeruloplasmin and iron transferrin levels in patients with non-Hodgkin's lymphoma.

Authors:  M Foster; A Dawson; T Pockington; L Fell
Journal:  Clin Radiol       Date:  1977-01       Impact factor: 2.350

3.  Serum copper correlations with bone marrow.

Authors:  C F Tessmer; M Hrgovcic; B W Brown; J Wilbur; F B Thomas
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

4.  Value of laboratory indicators in Hodgkin's disease: preliminary results.

Authors:  G R Ray; P H Wolf; H S Kaplan
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

5.  Serum copper levels in lymphoma and leukemia. Special reference to Hodgkin's disease.

Authors:  M Hrgovcic; C F Tessmer; T M Minckler; B Mosier; G H Taylor
Journal:  Cancer       Date:  1968-04       Impact factor: 6.860

6.  Significance of serum copper levels in adult patients with Hodgkin's disease.

Authors:  M Hrgovcic; C F Tessmer; F B Thomas; L M Fuller; J F Gamble; C C Shullenberger
Journal:  Cancer       Date:  1973-06       Impact factor: 6.860

7.  The ferrous to ferric cycles in iron metabolism.

Authors:  E Frieden
Journal:  Nutr Rev       Date:  1973-02       Impact factor: 7.110

8.  The serum iron level, hematocrit, sedimentation rate, and leukocyte alkaline phosphatase level in pediatric patients with Hodgkin's disease.

Authors:  N Jaffe; J M Bishop
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860

9.  A study of electron spin resonance spectra of whole blood from normal and tumour bearing patients.

Authors:  M A Foster; T Pocklington; J D Miller; J R Mallard
Journal:  Br J Cancer       Date:  1973-10       Impact factor: 7.640

10.  Iron metabolism in Hodgkin's disease.

Authors:  M R Beamish; P A Jones; D Trevett; I H Evans; A Jacobs
Journal:  Br J Cancer       Date:  1972-12       Impact factor: 7.640
View more
  1 in total

1.  Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors.

Authors:  Jami Mandelin; Marina Cardó-Vila; Wouter H P Driessen; Paul Mathew; Nora M Navone; Sue-Hwa Lin; Christopher J Logothetis; Anna Cecilia Rietz; Andrey S Dobroff; Bettina Proneth; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-11       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.